This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2018-2019.
Company Filing History:
Years Active: 2018-2019
Title: Huanan Liu - Innovator in Neurological Treatments.
Introduction
Huanan Liu is a notable inventor based in China, recognized for his contributions to the field of neurological medicine. His work focuses on developing innovative compounds that can effectively treat various neurological diseases. Liu's research aims to enhance the efficacy and safety of treatments for conditions such as epilepsy and neuropathic pain.
Latest Patents
Liu's most significant patent is titled "A Novel Kcnq Potassium Channel Agonist, The Preparation Method Therefor And Use Thereof." This invention provides a compound represented by a specific general formula, along with its preparation method and applications in medicine. The compound is designed to treat neurological diseases, including epilepsy, convulsions, and neurodegenerative disorders. Notably, it demonstrates improved absorption in brain tissue compared to existing treatments, such as RTG. Furthermore, the compound exhibits enhanced efficacy and significantly lower neurotoxicity, offering a wider safety window for patients.
Career Highlights
Throughout his career, Huanan Liu has focused on advancing the understanding and treatment of neurological conditions. His innovative approach to drug development has positioned him as a key figure in the field. Liu's dedication to research and development has led to promising advancements in therapeutic options for patients suffering from debilitating neurological diseases.
Collaborations
Liu has collaborated with Fajun Nan, contributing to the development of his patented compound. Their partnership has been instrumental in refining the preparation methods and enhancing the therapeutic potential of their inventions.
Conclusion
Huanan Liu's work in developing a novel Kcnq potassium channel agonist represents a significant advancement in the treatment of neurological diseases. His innovative approach and commitment to improving patient outcomes highlight the importance of continued research in this critical area of medicine.